2024-01-31 09:39:06 ET
Summary
- Materialise NV currently exhibits better growth, margins and fundamentals than its main competitors, positioning itself well in an industry that is estimated to grow at a CAGR of 16% until 2032;
- The medical business unit (c.a. 38.5% of total revenues in 9M23) continues to achieve double-digit growth, with the appointment of the new CEO to focus strongly on this segment;
- Both the analysis of multiples and DCF here presented show that the current share valuation is 40-45% below its fundamental value.
Editor's note: Seeking Alpha is proud to welcome EuroEquity Research as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium. Click here to find out more » ...
Read the full article on Seeking Alpha
For further details see:
Materialise NV: Consolidation And New Developments To Emerge As A Rising Star In The Additive Manufacturing Industry